Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism

被引:48
作者
Staleva, L
Manga, P
Orlow, SJ [1 ]
机构
[1] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
关键词
D O I
10.1091/mbc.E02-05-0282
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mutations in the mouse p (pink-eyed dilution) and human P genes lead to melanosomal defects and ocular developmental abnormalities. Despite the critical role played by the p gene product in controlling tyrosinase processing and melanosome biogenesis, its precise biological function is still not defined. We have expressed p heterologously in the yeast Saccharomyces cereviside to study its function in greater detail. Immunofluorescence studies revealed that p reaches the yeast vacuolar membrane via the prevacuolar compartment. Yeast cells expressing p exhibited increased sensitivity to a number of toxic compounds, including arsenicals. Similarly, cultured murine melanocytes expressing a functional p gene were also found to be more sensitive to arsenical compounds compared with p-null cell lines. Intracellular glutathione, known to play a role in detoxification of arsenicals, was diminished by 50% in p-expressing yeast. By using the glutathione-conjugating dye monochlorobimane, in combination with acivicin, an inhibitor of vacuolar gamma-glutamyl cysteine transpeptidase, involved in the breakdown of glutathione, we found that p facilitates the vacuolar accumulation of glutathione. Our data demonstrate that the pink-eyed dilution protein increases cellular sensitivity to arsenicals and other metalloids and can modulate intracellular glutathione metabolism.
引用
收藏
页码:4206 / 4220
页数:15
相关论文
共 84 条
[21]   Cadmium-inducible expression of the yeast GSH1 gene requires a functional sulfur-amino acid regulatory network [J].
Dormer, UH ;
Westwater, J ;
McLaren, NF ;
Kent, NA ;
Mellor, J ;
Jamieson, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32611-32616
[22]   AFRICAN ORIGIN OF AN INTRAGENIC DELETION OF THE HUMAN-P GENE IN TYROSINASE POSITIVE OCULOCUTANEOUS ALBINISM [J].
DURHAMPIERRE, D ;
GARDNER, JM ;
NAKATSU, Y ;
KING, RA ;
FRANCKE, U ;
CHING, A ;
AQUARON, R ;
DELMARMOL, V ;
BRILLIANT, MH .
NATURE GENETICS, 1994, 7 (02) :176-179
[23]   Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter [J].
Egner, R ;
Rosenthal, FE ;
Kralli, A ;
Sanglard, D ;
Kuchler, K .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (02) :523-543
[24]   Sequential biochemotherapy versus chemotherapy for metastatic melanoma: Results from a phase III randomized trial [J].
Eton, O ;
Legha, SS ;
Bedikian, AY ;
Lee, JJ ;
Buzaid, AC ;
Hodges, C ;
Ring, SE ;
Papadopoulos, NE ;
Plager, C ;
East, MJ ;
Zhan, F ;
Benjamin, RS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2045-2052
[25]   IDENTIFICATION OF THE MEMBRANE COMPONENT OF THE ANION PUMP ENCODED BY THE ARSENICAL RESISTANCE OPERON OF R-FACTOR R773 [J].
FRANCISCO, MJDS ;
TISA, LS ;
ROSEN, BP .
MOLECULAR MICROBIOLOGY, 1989, 3 (01) :15-21
[26]   Pathways for protein disulphide bond formation [J].
Frand, AR ;
Cuozzo, JW ;
Kaiser, CA .
TRENDS IN CELL BIOLOGY, 2000, 10 (05) :203-210
[27]   Melanosomal tyrosine transport in normal and pink-eyed dilution murine melanocytes [J].
Gahl, WA ;
Potterf, B ;
DurhamPierre, D ;
Brilliant, MH ;
Hearing, VJ .
PIGMENT CELL RESEARCH, 1995, 8 (05) :229-233
[28]   THE MOUSE PINK-EYED DILUTION GENE - ASSOCIATION WITH HUMAN PRADER-WILLI AND ANGELMAN SYNDROMES [J].
GARDNER, JM ;
NAKATSU, Y ;
GONDO, Y ;
LEE, S ;
LYON, MF ;
KING, RA ;
BRILLIANT, MH .
SCIENCE, 1992, 257 (5073) :1121-1124
[29]   Pathways of As(III) detoxification in Saccharomyces cerevisiae [J].
Ghosh, M ;
Shen, J ;
Rosen, BP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5001-5006
[30]   A phase II study of neoadjuvant biochemotherapy for stage III melanoma [J].
Gibbs, P ;
Anderson, C ;
Pearlman, N ;
LaClaire, S ;
Becker, M ;
Gatlin, K ;
O'Driscoll, M ;
Stephens, J ;
Gonzalez, R .
CANCER, 2002, 94 (02) :470-476